title: Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.
abstract: OBJECTIVE
  Noncompliance with adjuvant hormonal therapy among women with breast cancer is common. Little is known about the impact of financial factors, such as co-payments, on noncompliance.
  
  
  METHODS
  We conducted a retrospective cohort study by using the pharmacy and medical claims database at Medco Health Solutions. Women older than age 50 years who were taking aromatase inhibitors (AIs) for resected breast cancer with two or more mail-order prescriptions, from January 1, 2007, to December 31, 2008, were identified. Patients who were eligible for Medicare were analyzed separately. Nonpersistence was defined as a prescription supply gap of more than 45 days without subsequent refill. Nonadherence was defined as a medication possession ratio less than 80% of eligible days.
  
  
  RESULTS
  Of 8110 women younger than age 65 years, 1721 (21.1%) were nonpersistent and 863 (10.6%) were nonadherent. Among 14,050 women age 65 years or older, 3476 (24.7%) were nonpersistent and 1248 (8.9%) were nonadherent. In a multivariate analysis, nonpersistence (ever/never) in both age groups was associated with older age, having a non-oncologist write the prescription, and having a higher number of other prescriptions. Compared with a co-payment of less than $30, a co-payment of $30 to $89.99 for a 90-day prescription was associated with less persistence in women age 65 years or older (odds ratio [OR], 0.69; 95% CI, 0.62 to 0.75) but not among women younger than age 65, although a co-payment of more than $90 was associated with less persistence both in women younger than age 65 (OR, 0.82; 95% CI, 0.72 to 0.94) and those age 65 years or older (OR, 0.72; 95% CI, 0.65 to 0.80). Similar results were seen with nonadherence.
  
  
  CONCLUSIONS
  We found that higher prescription co-payments were associated with both nonpersistence and nonadherence to AIs. This relationship was stronger in older women. Because noncompliance is associated with worse outcomes, future policy efforts should be directed toward interventions that would help patients with financial difficulties obtain life-saving medications.
authors: Herbert Irving Comprehensive Cancer Center, College of Physiciansand Surgeons, Columbia University, New York, NY, USA. ain1@columbia.edu
authors: Alfred I
authors: AI
authors: Neugut
authors: Milayna
authors: M
authors: Subar
authors: Elizabeth Ty
authors: ET
authors: Wilde
authors: Scott
authors: S
authors: Stratton
authors: Corey H
authors: CH
authors: Brouse
authors: Grace Clarke
authors: GC
authors: Hillyer
authors: Victor R
authors: VR
authors: Grann
authors: Dawn L
authors: DL
authors: Hershman
references: Health Educ Behav. 2008 Dec;35(6):835-54
references: 17909222
references: BMC Health Serv Res. 2008 Dec 23;8:272
references: 19102784
references: J Clin Oncol. 2006 Feb 20;24(6):848-55
references: 16418496
references: Int J Technol Assess Health Care. 2003 Summer;19(3):465-75
references: 12962333
references: Br J Gen Pract. 1999 Sep;49(446):705-10
references: 10756611
references: Blood. 2009 May 28;113(22):5401-11
references: 19349618
references: JAMA. 2007 Jul 4;298(1):61-9
references: 17609491
references: Cancer. 2007 Mar 1;109(5):832-9
references: 17243168
references: CA Cancer J Clin. 2009 Jan-Feb;59(1):56-66
references: 19147869
references: Ann Pharmacother. 2006 Jul-Aug;40(7-8):1280-88
references: 16868217
references: J Clin Oncol. 2009 Jul 20;27(21):3445-51
references: 19451445
references: BMJ. 1996 Sep 14;313(7058):665-9
references: 8811760
references: J Clin Oncol. 2010 May 10;28(14):2418-22
references: 20368559
references: BMC Health Serv Res. 2008 Apr 07;8:75
references: 18394200
references: Br J Cancer. 1999 Mar;79(7-8):1227-33
references: 10098764
references: JAMA. 2004 May 19;291(19):2344-50
references: 15150206
references: J Gen Intern Med. 1993 Jun;8(6):306-10
references: 8320574
references: Med Care. 1990 Oct;28(10):907-17
references: 2232921
references: J Clin Oncol. 2003 Feb 15;21(4):602-6
references: 12586795
references: Cochrane Database Syst Rev. 2008 Jan 23;(1):CD007017
references: 18254125
references: J Am Med Inform Assoc. 2003 Jan-Feb;10(1):11-5
references: 12509353
references: Gerontologist. 2009 Aug;49(4):447-62
references: 19460887
references: Patient Educ Couns. 2005 Oct;59(1):97-102
references: 16198223
references: Br J Cancer. 2008 Dec 2;99(11):1763-8
references: 18985046
references: Breast Cancer Res Treat. 2011 Apr;126(2):529-37
references: 20803066
references: Clin Ther. 2003 Dec;25(12):3147-61; discussion 3144-6
references: 14749153
references: Med Interface. 1996 Apr;9(4):122-8
references: 10156019
references: Crit Rev Oncol Hematol. 2010 Feb;73(2):156-66
references: 19299162
references: Lancet. 2005 May 14-20;365(9472):1687-717
references: 15894097
references: Med Care. 1997 Nov;35(11):1119-31
references: 9366891
references: J Clin Oncol. 2010 Sep 20;28(27):4120-8
references: 20585090
references: Pharmacoeconomics. 2007;25(6):481-96
references: 17523753
references: AIDS. 2011 Mar 27;25(6):825-34
references: 21252632
references: Eur J Clin Pharmacol. 2009 Nov;65(11):1105-12
references: 19636546
references: Med Interface. 1996 Mar;9(3):118-22
references: 10172582
references: Am J Hypertens. 2009 Apr;22(4):392-6
references: 19180061
references: Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000011
references: 18425859
references: J Clin Oncol. 2004 Aug 15;22(16):3309-15
references: 15310774
references: Breast Cancer Res Treat. 2006 Sep;99(2):215-20
references: 16541307
references: Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):565-74; discussion 575-7
references: 16514590
references: Patient Prefer Adherence. 2010 Jul 21;4:187-95
references: 20694180
references: Int J Nurs Stud. 2009 Nov;46(11):1505-15
references: 19394018
references: N Engl J Med. 2010 Apr 29;362(17):1553-5
references: 20375400
references: Breast Cancer Res Treat. 2007 Dec;106(2):229-38
references: 17245540
references: J Am Coll Surg. 2008 Jan;206(1):66-75
references: 18155570
references: Circulation. 2009 Jan 27;119(3):390-7
references: 19139387
references: J Clin Oncol. 2010 Aug 10;28(23):3784-96
references: 20625130
references: Clin Breast Cancer. 2008 Apr;8(2):155-61
references: 18621612
references: Int J Technol Assess Health Care. 2005 Spring;21(2):228-33
references: 15921063
references: J Natl Cancer Inst. 2009 Nov 18;101(22):1534-6
references: 19880814
references: J Clin Oncol. 2008 Feb 1;26(4):556-62
references: 18180462
references: Eur J Cancer. 2006 Sep;42(14):2271-6
references: 16644208
references: N Engl J Med. 2005 Aug 4;353(5):487-97
references: 16079372
references: Health Aff (Millwood). 2009 Jan-Feb;28(1):206-14
references: 19124872